Page last updated: 2024-09-03

iguratimod and Colitis

iguratimod has been researched along with Colitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, XL; Huang, ZM; Jiang, XP; Miao, L; Tang, L; Wang, SC; Xie, W; Yang, ZP	1

Other Studies

1 other study(ies) available for iguratimod and Colitis

Article	Year
Iguratimod ameliorates inflammatory responses by modulating the Th17/Treg paradigm in dextran sulphate sodium-induced murine colitis. Molecular immunology, 2018, Volume: 93 Topics: Animals; Chromones; Colitis; Dextran Sulfate; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression Regulation; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukins; Intestinal Mucosa; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Random Allocation; Specific Pathogen-Free Organisms; Spleen; Sulfonamides; T-Lymphocytes, Regulatory; Th17 Cells; Transcription Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2018

Article

Year

Iguratimod ameliorates inflammatory responses by modulating the Th17/Treg paradigm in dextran sulphate sodium-induced murine colitis.

Molecular immunology, 2018, Volume: 93

Topics: Animals; Chromones; Colitis; Dextran Sulfate; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression Regulation; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukins; Intestinal Mucosa; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Random Allocation; Specific Pathogen-Free Organisms; Spleen; Sulfonamides; T-Lymphocytes, Regulatory; Th17 Cells; Transcription Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2018